Canadian supermarket giant Loblaw Cos announced late last week that it has earned regulatory approval for its $11.03 billion buyout of Shoppers Drug Mart, according to reports.
The transaction combines two of the nation’s top retailers, resulting in the operation of thousands of groceries and pharmacies across Canada.
But the deal was not cleared by Canada’s Competition Bureau without concessions. Loblaw reportedly agreed to divest 18 outlets and, additionally, the Bureau imposed restrictions on contracts made between the conglomerate and suppliers to safeguard against price-fixing, reports say.
While the Bureau did not elaborate on what those restrictions were, reports say Loblaw said the agreements focus on a program that promotes price-matching between rivals.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI